Timing is Everything: Neoadjuvant Versus Adjuvant Immunotherapy in Patients with Resectable Metastatic Melanoma

Ann Surg Oncol. 2023 Nov;30(12):6953-6957. doi: 10.1245/s10434-023-14133-8. Epub 2023 Aug 19.

Authors

Ashley M Holder¹, Jennifer A Wargo², Merrick I Ross²

Affiliations

¹ Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. amholder@mdanderson.org.
² Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.

PMID: 37597079
DOI: 10.1245/s10434-023-14133-8

No abstract available

Publication types

Editorial